- Home
- WATT vs PPBT Comparison
WATT vs PPBT Comparison
Compare WATT & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WATT
- PPBT
- Stock Information
- Founded
- WATT 2012
- PPBT 2010
- Country
- WATT United States
- PPBT Israel
- Employees
- WATT N/A
- PPBT N/A
- Industry
- WATT Radio And Television Broadcasting And Communications Equipment
- PPBT Biotechnology: Pharmaceutical Preparations
- Sector
- WATT Technology
- PPBT Health Care
- Exchange
- WATT Nasdaq
- PPBT Nasdaq
- Market Cap
- WATT 9.1M
- PPBT 8.7M
- IPO Year
- WATT 2014
- PPBT N/A
- Fundamental
- Price
- WATT $0.42
- PPBT $3.17
- Analyst Decision
- WATT Strong Buy
- PPBT Strong Buy
- Analyst Count
- WATT 2
- PPBT 2
- Target Price
- WATT $2.25
- PPBT $126.50
- AVG Volume (30 Days)
- WATT 929.8K
- PPBT 23.2K
- Earning Date
- WATT 03-27-2025
- PPBT 03-07-2025
- Dividend Yield
- WATT N/A
- PPBT N/A
- EPS Growth
- WATT N/A
- PPBT N/A
- EPS
- WATT N/A
- PPBT N/A
- Revenue
- WATT $431,184.00
- PPBT N/A
- Revenue This Year
- WATT $95.75
- PPBT N/A
- Revenue Next Year
- WATT $834.07
- PPBT N/A
- P/E Ratio
- WATT N/A
- PPBT N/A
- Revenue Growth
- WATT N/A
- PPBT N/A
- 52 Week Low
- WATT $0.28
- PPBT $2.00
- 52 Week High
- WATT $2.70
- PPBT $20.60
- Technical
- Relative Strength Index (RSI)
- WATT 44.73
- PPBT 44.15
- Support Level
- WATT $0.42
- PPBT $3.01
- Resistance Level
- WATT $0.49
- PPBT $3.48
- Average True Range (ATR)
- WATT 0.04
- PPBT 0.22
- MACD
- WATT 0.00
- PPBT 0.03
- Stochastic Oscillator
- WATT 29.60
- PPBT 52.63
About WATT Energous Corporation
Energous Corp has developed wireless power networks technology (WPNT), consisting of semiconductor chipsets, software controls, hardware designs and antennas, that enable radio frequency (RF) based charging for Internet of Things (IoT) devices. Its products include Transmitter IC & Module, Receivers IC, Transmitter System and other tools.
About PPBT Purple Biotech Ltd.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.